Delivery Order SPE2DB22D3011-SPE2DB24FQ2KF

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,582.04 delivery order contract is for the supply of Ketorolac 30 mg/ml vial, a medication used for pain management. The contract has a completion date of December 20, 2023 and is a firm fixed-price arrangement. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $1,206.54 Firm Fixed Price Delivery Order is for the supply of Ketorolac 30 mg/ml vials, a prescription pain medication. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.40 firm fixed-price delivery order is for the supply of 4566728770 - Ketorolac 30 mg/ml vial, a pain management medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,529,542 units of Ketorolac 15 mg/ml vial. The $1,072.43 delivery order contract has a firm fixed price pricing type and a completion date of May 8, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,258.48 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a medication used for pain management. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Ketorolac 30mg/ml in quantities of 25 doses. The award, valued at $15,949.23, was made by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4562387715 KETOROLAC 15 MG/ML VIALML to the Defense Logistics Agency (DLA), a defense agency. The $1,689.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ketorolac 30 mg/ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,476.46, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Ketorolac 30 mg/ml vials. The award has a fixed-price delivery order contract type with a ceiling value of $2,287.60 and an ultimate completion date of May 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of 25 units of Ketorolac 30mg/ml, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order contract, valued at $7,759.71, has a completion date of November 12, 2024. This award is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2KF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ketorolac 30 mg/ml vials, a prescription pain medication. The $1,209.90 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 8, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award does not have a set-aside designation.

Generated 10/4/24, 9:26 AM